Lyme Disease is an infectious disease caused by bacteria of the Borrelia burgdorferi sensu lato complex and transmitted to humans primarily through the bites of infected Ixodes ticks. The term encompasses a group of closely related Borrelia species that vary geographically, with different species contributing to human disease in Europe and North America. Lyme disease can affect the skin, nervous system, joints and other tissues. Its manifestations can occur in stages, although the course is not identical in every patient and untreated infection does not necessarily produce the same sequence of symptoms in everyone.
Ixodes ticks acquire Borrelia bacteria while feeding on infected reservoir hosts and can subsequently transmit the organisms during later blood meals. Small mammals and other wildlife can contribute to maintaining the bacterial cycle, while larger animals can transport ticks without necessarily serving as efficient reservoirs. Transmission usually requires attachment of an infected tick for a period of time, although exact transmission dynamics depend on the tick, Borrelia species and circumstances. Lyme Disease is not normally spread through casual contact between humans, and the presence of a tick does not automatically mean that it carries Borrelia.
One of the best-known early manifestations of Lyme Disease is erythema migrans, an expanding skin lesion that develops at the site of infection in some patients. It is often, but not invariably, described as a target or bull's-eye rash; the appearance can vary considerably and may not resemble a classic ring. Fever, fatigue, headache and muscle or joint aches can accompany early infection. Later manifestations can include neurological disease, cardiac involvement and arthritis, with the exact pattern influenced by geography, infecting species and timing of treatment.
Diagnosis of Lyme Disease combines clinical assessment with laboratory testing when appropriate. An expanding erythema migrans lesion in a person with a compatible exposure history can be sufficient for clinical diagnosis in appropriate circumstances, whereas later disease may require serological evidence of an immune response to Borrelia. Standard serological approaches generally use a two-tier or modified two-tier strategy, depending on the laboratory and jurisdiction. Antibodies can take time to develop, so early testing can be negative despite infection. Conversely, antibodies can remain detectable after successful treatment, meaning that positive serology does not necessarily prove active infection.
Treatment of Lyme Disease generally involves appropriate antibiotics selected according to the clinical manifestation and patient circumstances. Early disease can often be treated effectively with oral antibiotics, while particular neurological, cardiac or joint manifestations can require different regimens or routes of administration. Prompt treatment is valuable because it reduces the risk of progression to later manifestations. Antibiotic selection and duration should follow evidence-based guidance because prolonged or repeated antibiotic courses do not automatically provide benefit for persistent nonspecific symptoms after appropriate treatment and can carry significant risks.
Prevention focuses on reducing tick exposure and detecting attached ticks promptly. Measures include wearing clothing that limits exposed skin, using appropriate repellents, avoiding or carefully navigating tick habitats, performing body checks after outdoor exposure and removing attached ticks promptly with suitable technique. Pets can transport ticks into domestic environments, so veterinary tick-control measures can contribute to household prevention. There is no need to panic after every tick encounter because only some ticks are infected and transmission risk varies by location and duration of attachment, but prompt removal and appropriate assessment are sensible preventive practices.
Lyme Disease has important geographical differences. In North America, Borrelia burgdorferi is the principal human pathogen, while Europe has several medically relevant Borrelia species. Clinical manifestations can therefore differ between regions, and diagnostic tests are designed around relevant local organisms. The disease's ecology also means that incidence can vary with landscape, climate, tick abundance, host populations and human recreational behaviour. Changes in environmental conditions can influence tick distribution and the geographical areas in which Lyme disease presents a meaningful risk.
Lyme Disease is sometimes confused with any illness following a tick bite, but a tick bite alone does not establish infection. It is also incorrect to assume that erythema migrans always has a perfect bull's-eye appearance or that absence of such a rash excludes Lyme disease. Persistent symptoms after treatment require careful clinical evaluation rather than automatically being interpreted as ongoing bacterial infection. Accurate diagnosis depends on combining symptoms, exposure history, geography and appropriately timed testing. Prevention, early recognition and evidence-based antibiotic treatment are central to reducing complications from this tick-borne bacterial disease.
